{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:00:56Z","timestamp":1792000856839,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Perioper Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Advances in cancer treatments over the past decades combining chemotherapy with novel technologies in immunotherapies, radiation therapies, and interventional radiology have prolonged life expectancy. Patients have more options for treatments of their primary or metastatic diseases. Increased procedural techniques amid an aging population with multiple comorbidities present risks and challenges in the perioperative period.<\/jats:p><jats:p>Chemotherapy remains the mainstay of cancer treatment, can be given intraoperatively, and is combined with other treatment modalities. Immunotherapy is particular to cancer cells while being less toxic to healthy cells. Cancer vaccines stimulate the immune system to stop disease progression. Oncolytic viruses enhance the immune system\u2019s cytotoxic effect and show promise to halt metastatic disease progression if present in the perioperative period. Novel techniques in radiation therapy combined with traditional treatments show enhanced survival. This review focuses on current cancer treatments encountered in the perioperative period.<\/jats:p>","DOI":"10.1186\/s13741-023-00315-1","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T09:01:59Z","timestamp":1686646919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Review of cancer therapies for the perioperative physician"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9473-0917","authenticated-orcid":false,"given":"Anahita","family":"Dabo-Trubelja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Gottumukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"315_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.mayocp.2013.11.007","volume":"89","author":"BM Aakre","year":"2014","unstructured":"Aakre BM, Efem RI, Wilson GA, Kor DJ, Eisenach JH. Postoperative acute respiratory distress syndrome in patients with previous exposure to bleomycin. Mayo Clin Proc. 2014;89:181\u20139. https:\/\/doi.org\/10.1016\/j.mayocp.2013.11.007.","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 3","key":"315_CR2","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.ihj.2018.06.011","volume":"70","author":"AM Abuosa","year":"2018","unstructured":"Abuosa AM, Elshiekh AH, Qureshi K, Abrar MB, Kholeif MA, Kinsara AJ, et al. Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin. Indian Heart J. 2018;70(Suppl 3):S96-100. https:\/\/doi.org\/10.1016\/j.ihj.2018.06.011.","journal-title":"Indian Heart J"},{"key":"315_CR3","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1200\/JCO.2008.19.9273","volume":"27","author":"R Adam","year":"2009","unstructured":"Adam R, Wicherts DA, de Haas RJ, Ciancio O, L\u00e9vi F, Paule B, Ducreux M, Azoulay D, Bismuth H, Castaing D. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 2009;27:1829\u201335. https:\/\/doi.org\/10.1200\/JCO.2008.19.9273.","journal-title":"J Clin Oncol"},{"key":"315_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/apm.12576","volume":"124","author":"P Alberts","year":"2016","unstructured":"Alberts P, Olmane E, Brok\u0101ne L, Krasti\u0146a Z, Romanovska M, Kup\u010ds K, Isajevs S, Proboka G, Erdmanis R, Nazarovs J, Venskus D. Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports. APMIS. 2016;124:896\u2013904. https:\/\/doi.org\/10.1111\/apm.12576.","journal-title":"APMIS"},{"key":"315_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/tcrm.2007.3.2.213","volume":"3","author":"JP Armand","year":"2007","unstructured":"Armand JP, Ribrag V, Harrousseau JL, Abrey L. Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors. Ther Clin Risk Manag. 2007;3:213\u201324. https:\/\/doi.org\/10.2147\/tcrm.2007.3.2.213.","journal-title":"Ther Clin Risk Manag"},{"issue":"20","key":"315_CR6","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","volume":"71","author":"MS Avila","year":"2018","unstructured":"Avila MS, Ayub-Ferreira SM, de Barros Wanderley MR, das Dores Cruz F, Gon\u00e7alves Brand\u00e3o SM, Rigaud VOC, et al. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial. J Am Coll Cardiol. 2018;71(20):2281\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"315_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40425-018-0398-7","volume":"6","author":"O Bakos","year":"2018","unstructured":"Bakos O, Lawson C, Rouleau S, Tai LH. Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity. J Immunother Cancer. 2018;6:86. https:\/\/doi.org\/10.1186\/s40425-018-0398-7.","journal-title":"J Immunother Cancer"},{"key":"315_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-30472-4_2","volume-title":"Safety of biologics therapy","author":"BA Baldo","year":"2016","unstructured":"Baldo BA. Monoclonal antibodies: introduction. In: Safety of biologics therapy. Cham: Springer; 2016. p. 29\u201356."},{"key":"315_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/imr.12573","volume":"280","author":"N Brix","year":"2017","unstructured":"Brix N, Tiefenthaller A, Anders H, Belka C, Lauber K. Abscopal, Immunological effects of radiotherapy: narrowing the gap between clinical and preclinical experiences. Immunol Rev. 2017;280:249\u201379. https:\/\/doi.org\/10.1111\/imr.12573.","journal-title":"Immunol Rev"},{"key":"315_CR10","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","volume":"68","author":"VT DeVita Jr","year":"2008","unstructured":"DeVita VT Jr, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68:8643\u201353. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-6611.","journal-title":"Cancer Res"},{"key":"315_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716078","author":"PM Forde","year":"2018","unstructured":"Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med. 2018. https:\/\/doi.org\/10.1056\/NEJMoa1716078.","journal-title":"N Engl J Med"},{"key":"315_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","volume":"28","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell. 2015;28:690\u2013714. https:\/\/doi.org\/10.1016\/j.ccell.2015.10.012.","journal-title":"Cancer Cell"},{"key":"315_CR13","first-page":"18","volume":"53","author":"RP Gehdoo","year":"2009","unstructured":"Gehdoo RP. Anticancer chemotherapy and its anesthetic implications (current concepts). Indian J Anaesth. 2009;53:18\u201329.","journal-title":"Indian J Anaesth"},{"key":"315_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-3-319-74766-8_26","volume-title":"Anesthesiology: a practical approach","author":"B Gourkanti","year":"2018","unstructured":"Gourkanti B, Mulvihill D, Kalariya J, Li Y. Radiotherapy and anesthesia. In: Goudra BG, Duggan M, Chidambaran V, Venkata HPK, Duggan E, Powell M, Singh PM, editors. Anesthesiology: a practical approach. Cham: Springer; 2018. p. 255\u201364."},{"key":"315_CR15","doi-asserted-by":"publisher","first-page":"480650","DOI":"10.5402\/2012\/480650","volume":"2012","author":"YS Guan","year":"2012","unstructured":"Guan YS, He Q, Wang MQ. Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol. 2012;2012:480650. https:\/\/doi.org\/10.5402\/2012\/480650.","journal-title":"ISRN Gastroenterol"},{"issue":"3","key":"315_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/TA.0000000000000757","volume":"79","author":"BC Gulack","year":"2015","unstructured":"Gulack BC, Englum BR, Lo DD, Nussbaum DP, Keenan JE, Scarborough JE, Shapiro ML. Leukopenia is associated with worse but not prohibitive outcomes following emergent abdominal surgery. J Trauma Acute Care Surg. 2015;79(3):437\u201343. https:\/\/doi.org\/10.1097\/TA.0000000000000757. P.M.I.D.:26307878;P.M.C.I.D.:PMC4805422.","journal-title":"J Trauma Acute Care Surg"},{"key":"315_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00130404-200307000-00008","volume":"9","author":"S Gupta","year":"2003","unstructured":"Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA. Hepatic artery embolization and chemoembolization for treating patients with metastatic carcinoid tumors: the MD. Anderson experience. Cancer J. 2003;9:261\u20137. https:\/\/doi.org\/10.1097\/00130404-200307000-00008.","journal-title":"Cancer J"},{"key":"315_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/01.aco.0000169240.14056.19","volume":"18","author":"E Huettemann","year":"2005","unstructured":"Huettemann E, Sakka SG. Anaesthesia and anticancer chemotherapeutic drugs. Curr Opin Anaesthesiol. 2005;18:307\u201314. https:\/\/doi.org\/10.1097\/01.aco.0000169240.14056.19.","journal-title":"Curr Opin Anaesthesiol"},{"key":"315_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1213\/01.ane.0000108135.52036.48","volume":"98","author":"E Huettemann","year":"2004","unstructured":"Huettemann E, Junker T, Chatzinikolaou KP, Petrat G, Sakka SG, Vogt L, Reinhart K. The influence of anthracycline therapy on cardiac function during anesthesia. Anesth Analg. 2004;98:941\u20137. https:\/\/doi.org\/10.1213\/01.ane.0000108135.52036.48. table of contents.","journal-title":"Anesth Analg"},{"key":"315_CR20","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1128\/JVI.00211-09","volume":"83","author":"M Jarahian","year":"2009","unstructured":"Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, Cerwenka A, Paschen A, Schirrmacher V, Momburg F. Activation of natural killer cells by Newcastle disease virus hemagglutinin-neuraminidase. J Virol. 2009;83:8108\u201321. https:\/\/doi.org\/10.1128\/JVI.00211-09.","journal-title":"J Virol"},{"key":"315_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bja\/aen395","volume":"102","author":"G Kessell","year":"2009","unstructured":"Kessell G, Panchatsharam S, Kothmann E, Finn P, Fall A, Guhan A, Muir T. General anesthesia for intralesional bleomycin therapy of vascular malformations: initial 3 yr experience. Br J Anaesth. 2009;102:431\u20132. https:\/\/doi.org\/10.1093\/bja\/aen395.","journal-title":"Br J Anaesth"},{"key":"315_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13046-019-1266-0","volume":"38","author":"S Kruger","year":"2019","unstructured":"Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, Schuebbe G, Renz BW, D\u2019Haese JG, Schloesser H, Heinemann V, Subklewe M, Boeck S, Werner J, von Bergwelt-Baildon M. Advances in immunotherapy 2019-latest trends. J Exp Clin Cancer Res. 2019;38:268. https:\/\/doi.org\/10.1186\/s13046-019-1266-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"315_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188\u201396. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.034.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"315_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccm.2017.01.002","volume":"38","author":"P Leger","year":"2017","unstructured":"Leger P, Limper AH, Maldonado F. Pulmonary toxicities from conventional chemotherapy. Clin Chest Med. 2017;38(2):209\u201322. https:\/\/doi.org\/10.1016\/j.ccm.2017.01.002. Epub 2017 Mar 1 PMID: 28477634.","journal-title":"Clin Chest Med"},{"issue":"3","key":"315_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bja.2019.11.034","volume":"124","author":"AL Lewis","year":"2020","unstructured":"Lewis AL, Chaft J, Girotra M, Fischer GW. Immune check-point inhibitors: a narrative review of considerations for the anesthesiologist. Br J Anaesth. 2020;124(3):251\u201360. https:\/\/doi.org\/10.1016\/j.bja.2019.11.034. Epub 2020 Jan 29. P.M.I.D.: 32007241; P.M.C.I.D.: PMC7890563.","journal-title":"Br J Anaesth"},{"key":"315_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1568009618666171129221503","volume":"18","author":"M Liang","year":"2018","unstructured":"Liang M. Oncorine, the world first oncolytic virus medicine and its update in China. Curr Cancer Drug Targets. 2018;18:171\u20136. https:\/\/doi.org\/10.2174\/1568009618666171129221503.","journal-title":"Curr Cancer Drug Targets"},{"key":"315_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/ALN.0b013e3181ed098d","volume":"113","author":"N Libert","year":"2010","unstructured":"Libert N, Tourtier J-P, V\u00e9drine L, Chargari C. Bruno Riou; Inhibitors of angiogenesis: new hopes for oncologists, new challenges for anesthesiologists. Anesthesiology. 2010;113:704\u201312. https:\/\/doi.org\/10.1097\/ALN.0b013e3181ed098d.","journal-title":"Anesthesiology"},{"key":"315_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/sj.gt.3301885","volume":"10","author":"BL Liu","year":"2003","unstructured":"Liu BL, Robinson M, Han ZQ, Branston RH, English C, Reay P, McGrath Y, Thomas SK, Thornton M, Bullock P, Love CA, Coffin RS. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune-stimulating, and antitumor properties. Gene Ther. 2003;10:292\u2013303. https:\/\/doi.org\/10.1038\/sj.gt.3301885.","journal-title":"Gene Ther."},{"key":"315_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrc1815","volume":"6","author":"PL Lollini","year":"2006","unstructured":"Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumor prevention. Nat Rev Cancer. 2006;6:204\u201316. https:\/\/doi.org\/10.1038\/nrc1815.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"315_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00384-021-04021-6","volume":"37","author":"M Lundbech","year":"2022","unstructured":"Lundbech M, Krag AE, Iversen LH, Hvas AM. Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(1):17\u201333. https:\/\/doi.org\/10.1007\/s00384-021-04021-6. Epub 2021 Oct 9 PMID: 34626208.","journal-title":"Int J Colorectal Dis"},{"key":"315_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fphar.2014.00051","volume":"5","author":"ML Mancini","year":"2014","unstructured":"Mancini ML, Sonis ST. Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities. Front Pharmacol. 2014;5:51. https:\/\/doi.org\/10.3389\/fphar.2014.00051.","journal-title":"Front Pharmacol"},{"issue":"9","key":"315_CR32","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1097\/CCM.0b013e3181a590da","volume":"37","author":"PE Marik","year":"2009","unstructured":"Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37(9):2642\u20137. https:\/\/doi.org\/10.1097\/CCM.0b013e3181a590da.","journal-title":"Crit Care Med"},{"key":"315_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2217\/fvl-2016-0129","volume":"12","author":"J Maroun","year":"2017","unstructured":"Maroun J, Mu\u00f1oz-Al\u00eda M, Ammayappan A, Schulze A, Peng KW, Russell S. Designing and building oncolytic viruses. Future Virol. 2017;12:193\u2013213. https:\/\/doi.org\/10.2217\/fvl-2016-0129.","journal-title":"Future Virol"},{"key":"315_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5334\/jbsr.1727","volume":"103","author":"M Midulla","year":"2019","unstructured":"Midulla M, Pescatori L, Chevallier O, Nakai M, Ikoma A, Gehin S, Berthod PE, Ne R, Loffroy R, Dake M. Future of IR: emerging techniques, looking to the future and learning from the past. J Belg Soc Radiol. 2019;103:12. https:\/\/doi.org\/10.5334\/jbsr.1727.","journal-title":"J Belg Soc Radiol"},{"key":"315_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.amsu.2018.09.036","volume":"35","author":"SA Naffouje","year":"2018","unstructured":"Naffouje SA, Tulla KA, Chorley R, Armstrong N, Salti GI. Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC. Ann Med Surg (Lond). 2018;35:163\u20138. https:\/\/doi.org\/10.1016\/j.amsu.2018.09.036.","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"315_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/j.ackd.2019.08.005","volume":"27","author":"A Nicolaysen","year":"2020","unstructured":"Nicolaysen A. Nephrotoxic chemotherapy agents: old and new. Adv Chronic Kidney Dis. 2020;27(1):38\u201349. https:\/\/doi.org\/10.1053\/j.ackd.2019.08.005. PMID: 32147000.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"315_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/2042098614529603","volume":"5","author":"AA Onitilo","year":"2014","unstructured":"Onitilo AA, Engel JM, Stankowski RV. Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors. Ther Adv Drug Saf. 2014;5(4):154\u201366. https:\/\/doi.org\/10.1177\/2042098614529603. PMID:25083270;PMCID:PMC4110857.","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"315_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/cancers11040550","volume":"11","author":"F Petrelli","year":"2019","unstructured":"Petrelli F, Zaniboni A, Ghidini A, Ghidini M, Turati L, Pizzo C, Ratti M, Libertini M, Tomasello G. Timing of adjuvant chemotherapy and survival in colorectal, gastric, and pancreatic cancer. A systematic review and meta-analysis. Cancers (Basel). 2019;11(4):550. https:\/\/doi.org\/10.3390\/cancers11040550. P.M.I.D.:30999653;P.M.C.I.D.:PMC6520704.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"315_CR39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/cancers11071033","volume":"11","author":"G Planes-Laine","year":"2019","unstructured":"Planes-Laine G, Rochigneux P, Bertucci F, Chr\u00e9tien AS, Viens P, Sabatier R, Gon\u00e7alves A. PD-1\/PD-L1 targeting in breast cancer: the first clinical evidences are emerging. A literature review. Cancers (Basel). 2019;11(7):1033. https:\/\/doi.org\/10.3390\/cancers11071033. PMID:31336685;PMCID:PMC6679223.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"315_CR40","doi-asserted-by":"publisher","first-page":"9881","DOI":"10.5812\/hepatmon.19881","volume":"14","author":"P Rahimzadeh","year":"2014","unstructured":"Rahimzadeh P, Safari S, Faiz SH, Alavian SM. Anesthesia for patients with liver disease. Hepat Mon. 2014;14(7):9881. https:\/\/doi.org\/10.5812\/hepatmon.19881. P.M.I.D.: 25031586; P.M.C.I.D.: PMC4080095.","journal-title":"Hepat Mon"},{"key":"315_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12967-014-0262-6","volume":"12","author":"L Ridolfi","year":"2014","unstructured":"Ridolfi L, de Rosa F, Ridolfi R, Gentili G, Valmorri L, Scarpi E, Parisi E, Romeo A, Guidoboni M. Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose interleukin-2: evaluation of biomarkers of immunologic and therapeutic response. J Transl Med. 2014;12:262. https:\/\/doi.org\/10.1186\/s12967-014-0262-6.","journal-title":"J Transl Med"},{"key":"315_CR42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-018-2484-0","volume":"474","author":"MW Rohaan","year":"2019","unstructured":"Rohaan MW, Wilgenhof S, Haanen JBAG. Adoptive cellular therapies: the current landscape. Virchows Arch. 2019;474:449\u201361. https:\/\/doi.org\/10.1007\/s00428-018-2484-0.","journal-title":"Virchows Arch"},{"key":"315_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/bcpt.12313","volume":"116","author":"GV R\u00f8sland","year":"2015","unstructured":"R\u00f8sland GV, Engelsen AST. Novel points of attack for targeted cancer therapy. Basic Clin Pharmacol Toxicol. 2015;116:9\u201318. https:\/\/doi.org\/10.1111\/bcpt.12313.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"315_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/cco.2018.04.04","volume":"7","author":"L Russell","year":"2018","unstructured":"Russell L, Peng KW. The emerging role of oncolytic virus therapy against cancer. Chin Clin Oncol. 2018;7:16. https:\/\/doi.org\/10.21037\/cco.2018.04.04.","journal-title":"Chin Clin Oncol"},{"key":"315_CR45","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1245\/s10434-015-5020-3","volume":"23","author":"RA Sanford","year":"2016","unstructured":"Sanford RA, Lei X, Barcenas CH, et al. Impact of time from completion of neoadjuvant chemotherapy to surgery on survival outcomes in breast cancer patients. Ann Surg Oncol. 2016;23:1515\u201321. https:\/\/doi.org\/10.1245\/s10434-015-5020-3.","journal-title":"Ann Surg Oncol"},{"key":"315_CR46","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2011.08.017","volume":"83","author":"DL Schwartz","year":"2012","unstructured":"Schwartz DL, Garden AS, Thomas J, Chen Y, Zhang Y, Lewin J, Chambers MS, Dong L. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012;83:986\u201393. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.08.017.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"315_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1293\/tox.2015-0031","volume":"28","author":"M Suzuki","year":"2015","unstructured":"Suzuki M, Kato C, Kato A. Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies. J Toxicol Pathol. 2015;28:133\u20139. https:\/\/doi.org\/10.1293\/tox.2015-0031.","journal-title":"J Toxicol Pathol"},{"key":"315_CR48","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/pds.4555","volume":"27","author":"H Svanstr\u00f6m","year":"2018","unstructured":"Svanstr\u00f6m H, Lund M, Melbye M, Pasternak B. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis. Pharmacoepidemiol Drug Saf. 2018;27:885\u201393. https:\/\/doi.org\/10.1002\/pds.4555.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"315_CR49","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1158\/1078-0432.CCR-13-0246","volume":"19","author":"LH Tai","year":"2013","unstructured":"Tai LH, Zhang J, Scott KJ, de Souza CT, Alkayyal AA, Ananth AA, Sahi S, Adair RA, Mahmoud AB, Sad S, Bell JC, Makrigiannis AP, Melcher AA, Auer RC. Perioperative influenza vaccination reduces postoperative metastatic disease by reversing surgery-induced dysfunction in natural killer cells. Clin Cancer Res. 2013;19:5104\u201315. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0246.","journal-title":"Clin Cancer Res"},{"key":"315_CR50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1053\/j.seminoncol.2015.05.007","volume":"42","author":"JA Wargo","year":"2015","unstructured":"Wargo JA, Reuben A, Cooper ZA, Oh KS, Sullivan RJ. Immune effects of chemotherapy, radiation, targeted therapy, and opportunities for combination with immunotherapy. Semin Oncol. 2015;42:601\u201316. https:\/\/doi.org\/10.1053\/j.seminoncol.2015.05.007.","journal-title":"Semin Oncol"},{"key":"315_CR51","doi-asserted-by":"publisher","first-page":"750507","DOI":"10.3389\/fphar.2022.750507","volume":"13","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, Rudd JA, Kulmira N, Raquel A. Mechanisms of chemotherapy-induced neurotoxicity. Front Pharmacol. 2022;13:750507. https:\/\/doi.org\/10.3389\/fphar.2022.750507.","journal-title":"Front Pharmacol"},{"key":"315_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nri2744","volume":"10","author":"LM Weiner","year":"2010","unstructured":"Weiner LM, Surana R, Wang S. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nat Rev Immunol. 2010;10:317\u201327. https:\/\/doi.org\/10.1038\/nri2744.","journal-title":"Nat Rev Immunol"}],"container-title":["Perioperative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-023-00315-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13741-023-00315-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-023-00315-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T09:22:13Z","timestamp":1686648133000},"score":1,"resource":{"primary":{"URL":"https:\/\/perioperativemedicinejournal.biomedcentral.com\/articles\/10.1186\/s13741-023-00315-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1186\/s13741-023-00315-1","relation":{},"ISSN":["2047-0525"],"issn-type":[{"value":"2047-0525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}